• Skip to main content

DistilNFO HealthPlan

DISTILNFO PAYER ADVISORY

  • Publications
    • DistilNFO HealthPlan
    • DistilNFO HospitalIT
    • DistilNFO IT
    • DistilNFO Retail
    • DistilNFO POPHealth
    • DistilNFO HITRUST
    • DistilNFO Ageing
    • DistilNFO Safety
    • DistilNFO Life Sciences
    • DistilNFO GovHealth
    • Subscribe
    • Submit Article
    • Advertise

Cigna Tells Regulators It Moved Fast On $67 Billion Express Scripts Deal

Share:

March 27, 2018

Highlights on this story:
  • Cigna said it acted because the $67 billion tie-up is the “most effective means to accelerate” its strategy of clinical and medical management, it said in a filing Tuesday with the U.S. Securities and Exchange Commission.
  • The deal more efficiently uses capital than the Aetna-CVS deal, which is built on a bricks and mortar premise.

Cigna Corp. began its pursuit of Express Scripts Holding Co. in October 2017, not waiting for regulators to rule on a separate deal between CVS Health Corp. and Aetna Inc., the Bloomfield health insurer said in a filing with securities regulators.

Cigna said it acted because the $67 billion tie-up is the “most effective means to accelerate” its strategy of clinical and medical management, it said in a filing Tuesday with the U.S. Securities and Exchange Commission.

“Pharmacy is the most frequently consumed health care product for Americans and is the No. 1 cause of gaps in care,” Cigna said. “Our combination allows Cigna to fully leverage Express Scripts’ leading pharmacy management capabilities, including its specialty pharmacy capabilities.”

The combination of the two companies is expected to provide a “highly specialized and personalized” approach for consumers, resulting in high consumer satisfaction, better treatment and better health outcomes, it said.

Want to publish your own articles on DistilNFO Publications?

Send us an email, we will get in touch with you.

Express Scripts became a “preferred option due to its market-leading capabilities,” Cigna said.

Cigna and Express Scripts announced the acquisition by the Bloomfield health insurer March 8. The two companies say the deal will help control health care costs as consolidation picks up in the insurance and pharmacy benefits management industries.

Cigna said it expects to drive revenue growth to between 6 percent and 8 percent, from 4.5 percent, despite growth by Express Scripts in the low single digits. Express Scripts also will account for about two-thirds of the revenue of the combined company.

Cigna said it expects employer customer overlaps of about 30 percent, with a “substantial cross-selling opportunity” for products and services.

And it said it can expand its services into health plans and government entities now served by Express Scripts.

By leveraging Express Scripts’ pharmacy management services, Cigna will “more deeply drive” value-based models with health care providers and pharmaceutical manufacturers, Cigna said.

Leerink Research analyst Ana Gupte said in a client note Wednesday the deal faces a long regulatory review.

The stock is “likely in anti-trust purgatory for the next several months” and possibly through the end of the year, she said.

The deal more efficiently uses capital than the Aetna-CVS deal, which “is built on a bricks and mortar premise,” she said.

The deal bringing Aetna into an enlarged CVS is expected to provide a coast-to-coast chain of stores, including 9,700 retail sites and 1,600 in Target stores.

Cigna also said it sees the January announcement of a health care alliance by Amazon Inc., Berkshire Hathaway Inc. and JPMorgan Chase & Co. as consistent with widespread opinions that the health care system is unsustainable.

“We welcome additional voices to change the status quo and we believe there are potential partnership opportunities,” the company said.

Shares of Cigna closed up more than 2 percent, at $167.05. Express Scripts shares were down 1 percent, at $71.68

Date: March 22, 2018

Source: Courant

Liked this story?

Get top 10 stories like these delivered to your inbox weekly. [Sample Newsletter]

Love Reading DistilNFO Healthplan?

Like us on Facebook.
Follow us on Linkedin.
Join e-Newsletter: Subscribe

Related Stories

  • Anthem’s Move To End PBM Deal Latest Scrape With CignaAnthem’s Move To End PBM Deal Latest Scrape With Cigna
  • Anthem to release PBM earlier than expected: 4 things to knowAnthem to release PBM earlier than expected: 4 things to know
  • Cigna stock will face drug pricing risk for foreseeable future, Barron’s saysCigna stock will face drug pricing risk for foreseeable future, Barron’s says
  • CVS, Humana could lose out in Centene-WellCare dealCVS, Humana could lose out in Centene-WellCare deal
  • Cigna Invests In GNS Healthcare Precision Medicine VentureCigna Invests In GNS Healthcare Precision Medicine Venture
  • Cigna to Acquire Express Scripts for $67B to Expand Consumer ValueCigna to Acquire Express Scripts for $67B to Expand Consumer Value
  • With Or Without CVS, Bertolini Describes Aetna’s FutureWith Or Without CVS, Bertolini Describes Aetna’s Future
  • Cigna shareholders approve $52B Express Scripts mergerCigna shareholders approve $52B Express Scripts merger

Trending This Week

  • Here’s Why UnitedHealth, Humana, and Cigna Soared in November
  • Why Anthem Doesn’t Want to Own Physician Practices
  • Humana Accidentally Auto-Billed 25,000 Members for 100 Times Their Owed Fees
  • Mergers and Acquisitions Will Strengthen Payer Identity in 2020
  • UnitedHealth’s Optum to Buy Diplomat Specialty Pharmacy for $300M
  • CVS Health Announces Successful First Year of Aetna Integration at One Year Anniversary

About Us

DistilNFO is media company that publishes Industry news, views and Interviews. We distil the information for you – saving time and keeping you up to date on your interest areas.

More About Us

Useful Links

  • Subscribe
  • Contact
  • Advertise
  • Privacy Policy
  • Terms of Service
  • Feedback

Follow Us

© DistilNFO Publications